We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4307:TSENomura Research Institute,Ltd. Analysis

Data as of 2026-03-13 - not real-time

¥4,305.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Nomura Research Institute shows solid fundamentals with a price‑earnings multiple comfortably below the industry average and a modest dividend yield supported by a healthy payout ratio. Low beta suggests limited market‑wide volatility, yet the stock exhibits high recent price volatility and a bearish technical backdrop, as price sits above the short‑term moving average but remains under longer‑term averages. Recent earnings highlight a domestic revenue surge that offsets an overseas industrial IT loss, underscoring a resilient core business. Analyst consensus remains positive, with a majority rating of buy, but the combination of decreasing volume and a bearish trend calls for caution in the near term.
Given the undervalued valuation relative to peers, strong cash generation, and sustainable dividend, the medium‑ to long‑term outlook is favorable. Investors should monitor the overseas segment recovery and volume trends, while the current price still offers upside potential against the fair‑value estimates.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical trend with price below longer‑term averages
  • Decreasing trading volume indicating weaker short‑term liquidity
  • Support level providing downside protection

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to industry PE and upside potential
  • Strong domestic earnings momentum
  • Low beta reducing market risk

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend supported by solid cash flow
  • Strategic positioning in IT platform and data centre services
  • Robust return on equity and consistent profitability

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin13.16%
P/E Ratio23.9
ROE22.70%
ROA10.25%
Debt/Equity46.81
P/B Ratio4.9
Op. Cash Flow¥143.4B
Free Cash Flow¥37.1B
Industry P/E33.7

Technical Analysis

TrendBearish
RSI46.9
Support¥3,518.00
Resistance¥4,450.00
MA 20¥4,100.20
MA 50¥4,956.58
MA 200¥5,624.20
MACDBullish
VolumeDecreasing
Fear & Greed Index72.41

Valuation

Fair Value¥983.98
Target Price¥5,933.33
Upside/Downside37.82%
GradeUndervalued
TypeBlend
Dividend Yield1.75%

Risk Assessment

Beta0.33
Volatility81.93%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.